Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Molecular Biosciences"
DOI: 10.3389/fmolb.2022.930207
Abstract: Oncolytic viruses have made a significant inroad in cancer drug development. Numerous clinical trials are currently investigating oncolytic viruses both as single agents or in combination with various immunomodulators. Oncolytic viruses (OV) are an integral… read more here.
Keywords: tem8 antxr1; biomarker; valley virus; seneca valley ... See more keywords